Designed to give you deeper insights into an individual’s immune response to any infection, including the SARS-CoV-2 virus.
¹ Kang R, et al. HMGB1 in health and disease. Mol Aspects Med, 2014, 40, 1-116.
² Andersson U, et al. Extracellular HMGB1: A therapeutic target in severe pulmonary inflammation including COVID-19? Mol Med, 2020, 26, 42. doi: 10.1186/s10020-020-00172-4